Purpose
to support the development of the cell line for manufacturing of a pilot lot of gp120 Clade B/E protein for a Phase I bridging study
Grantee
Division
Global Health
Date
NOVEMBER 2012
Region served
GLOBAL
Committed amount
$2,098,761
Grant topic
HIV
Duration (months)
40
Grantee location
Rixensart, Antwerpen, Belgium
Related work
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.